AGP Picks
View all

The Latin American Examiner
Provided by AGP

The Latin American Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on June 4, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies
Jun. 4, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies

Indeterminate GlobeNewswire
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Jun. 4, 2026

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution

Indeterminate GlobeNewswire
Aya Gold & Silver Releases its 2025 Sustainability Report
Jun. 4, 2026

Aya Gold & Silver Releases its 2025 Sustainability Report

Indeterminate GlobeNewswire
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
Jun. 4, 2026

Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease

Indeterminate GlobeNewswire
Onco360® Has Been Selected as a National Specialty Pharmacy Provider for JYLAMVO® (methotrexate) Oral Solution
Jun. 4, 2026

Onco360® Has Been Selected as a National Specialty Pharmacy Provider for JYLAMVO® (methotrexate) Oral Solution

Indeterminate GlobeNewswire
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society
Jun. 4, 2026

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society

Indeterminate GlobeNewswire
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026
Jun. 4, 2026

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026

Indeterminate GlobeNewswire
Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial
Jun. 4, 2026

Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial

Indeterminate GlobeNewswire
Bitget Rolls Out Stocks 2.0, Linking Tokenized Equities to Real U.S. Market Liquidity
Jun. 4, 2026

Bitget Rolls Out Stocks 2.0, Linking Tokenized Equities to Real U.S. Market Liquidity

Indeterminate GlobeNewswire
InterPrivate Investment Partners V, Inc. Announces Pricing of $175 Million Initial Public Offering
Jun. 4, 2026

InterPrivate Investment Partners V, Inc. Announces Pricing of $175 Million Initial Public Offering

Indeterminate GlobeNewswire
CoinEx Monthly | Derisking Above, Building Below
Jun. 4, 2026

CoinEx Monthly | Derisking Above, Building Below

Indeterminate GlobeNewswire
Onchain Stocks Hit $5.5 Billion in Volume, Yet Most Trading Still Follows U.S. Market Hours, New Report Finds
Jun. 4, 2026

Onchain Stocks Hit $5.5 Billion in Volume, Yet Most Trading Still Follows U.S. Market Hours, New Report Finds

Indeterminate GlobeNewswire
CoinEx Completes May 2026 CET Repurchase Burn, Reinforcing Long-Term Ecosystem Value
Jun. 4, 2026

CoinEx Completes May 2026 CET Repurchase Burn, Reinforcing Long-Term Ecosystem Value

Indeterminate GlobeNewswire
Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
Jun. 4, 2026

Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS

Indeterminate GlobeNewswire
ダークホース・コンサルティング・グループとアルトゥルイスト、中国におけるバイオ医薬品の製造・開発を推進するための覚書を締結
Jun. 4, 2026

ダークホース・コンサルティング・グループとアルトゥルイスト、中国におけるバイオ医薬品の製造・開発を推進するための覚書を締結

Indeterminate GlobeNewswire
Dark Horse Consulting Group·Altruist Biologics, 중국 생물의약품 개발·생산 협력 위한 양해각서 체결
Jun. 4, 2026

Dark Horse Consulting Group·Altruist Biologics, 중국 생물의약품 개발·생산 협력 위한 양해각서 체결

Indeterminate GlobeNewswire
Dark Horse Consulting Group dan Altruist Biologics Mengumumkan Memorandum Persefahaman untuk Memajukan Pembangunan dan Pembuatan Produk Biologi di China
Jun. 4, 2026

Dark Horse Consulting Group dan Altruist Biologics Mengumumkan Memorandum Persefahaman untuk Memajukan Pembangunan dan Pembuatan Produk Biologi di China

Indeterminate GlobeNewswire
Dark Horse Consulting Group 与 Altruist Biologics 宣布签署谅解备忘录，共同推进中国生物制剂生产与开发
Jun. 4, 2026

Dark Horse Consulting Group 与 Altruist Biologics 宣布签署谅解备忘录，共同推进中国生物制剂生产与开发

Indeterminate GlobeNewswire
Dark Horse Consulting Group 與 Altruist Biologics 宣佈簽訂合作備忘錄，推動中國生物製劑的生產與開發
Jun. 4, 2026

Dark Horse Consulting Group 與 Altruist Biologics 宣佈簽訂合作備忘錄，推動中國生物製劑的生產與開發

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Latin American Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.